ATLANTA— State Representative Keisha Waites (D-Atlanta) today released the following statement regarding Governor Deal’s executive order to remove the question about felony convictions from state employment applications: Continue reading “Rep. Keisha Waites Praises Governor Deal’s Executive Order to ‘Ban the Box’”
Rep. Waites pushes for Women and Minority Business Participation Plan
ATLANTA— State Representative Keisha Waites (D-Atlanta) recently introduced an amendment to House Bill 170, also known as the Transportation Funding Act of 2015. Rep. Waites’ amendment would ensure minority participation in Georgia’s transportation construction work. Continue reading “Rep. Waites pushes for Women and Minority Business Participation Plan”
Medical Cannabis: One Step Closer
By State Representative Allen Peake (R-Macon)
(657 words)
On Wednesday of this week, 157 of my House colleagues joined me in voting in support of HB 1, Haleigh’s Hope Act, the medical cannabis oil bill. Continue reading “Medical Cannabis: One Step Closer”
House Passes Medical Cannabis Legislation, Co-Sponsored by Rep. Micah Gravley
ATLANTA — The Georgia House of Representatives yesterday passed House Bill 1, or the Haleigh’s Hope Act, by a vote of 158-2. HB 1, sponsored by State Representative Allen Peake (R-Macon) and co-sponsored by Rep. Micah Gravley (R-Douglasville), would decriminalize the possession of medical cannabis in Georgia. Continue reading “House Passes Medical Cannabis Legislation, Co-Sponsored by Rep. Micah Gravley”
Guest Editorial: Biosimilars Provide New Treatment Options, but Communication is Critical to Patient Care
By State Representative Sharon Cooper
(892 words)
Just as the new year brings exciting opportunities, as well as challenges, each new session of the Georgia General Assembly presents legislators with a myriad of issues that must be addressed. As Chairman of the House Health and Human Services Committee one such item my committee must deal with is the development of a set of guidelines for the use of a new group of innovative drugs that may soon be on the market. Continue reading “Guest Editorial: Biosimilars Provide New Treatment Options, but Communication is Critical to Patient Care”